News
DARZALEX Faspro® is co-formulated with Halozyme's ENHANZE® drug delivery technology Approval represents critical advancement ...
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its second quarter 2025 financial and ...
A settlement between Philips and Transsion and a loss for AstraZeneca in the UK were also among the top talking points ...
Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce the voting results of the Company's annual and special ...
We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’ Substack by Kontra. In this article, we will summarize the bull’s thesis on TEVA.
In Springfield and elsewhere in the state, vacant license offices force residents to travel — before waiting in line — to renew plates and licenses.
Family offices are looking to diversify in the face of geopolitical uncertainty, a company survey found.
Americares, in partnership with the Healthcare Distribution Alliance, presented its annual Power of Partnership Award to Teva Pharmaceuticals in recognition of its outstanding commitment to ...
Teva So the original can tackle more aggressive terrain, whereas the sleeker R2T, as its name suggests, straddles the line between road and trail. It’s almost like a mountain bike versus a gravel bike ...
Anti-ICE riots forced temporary closures of HUD offices in Los Angeles, San Francisco and New York as Secretary Turner refutes Democrats' earlier claims about permanent shutdowns.
In 2020, we committed to launching eight Access to Medicines programs by 2025, aimed at providing treatments to underserved populations worldwide via customized, localized models conducted with ...
Teva outlines its accelerated growth strategy focused on innovation, aiming for $5 billion in biopharma revenue by 2030, while maintaining a strong generics and biosimilars base.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results